152 related articles for article (PubMed ID: 11787243)
21. Vaginal and endocervical microorganisms in symptomatic and asymptomatic non-pregnant females: risk factors and rates of occurrence.
Tibaldi C; Cappello N; Latino MA; Masuelli G; Marini S; Benedetto C
Clin Microbiol Infect; 2009 Jul; 15(7):670-9. PubMed ID: 19558525
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of trichomonas vaginalis in patients with vaginal discharge in Lagos, Nigeria.
Anorlu RI; Fagbenro Beyioku AF; Fagorala T; Abudu OO; Galadanci HS
Niger Postgrad Med J; 2001 Dec; 8(4):183-6. PubMed ID: 11922025
[TBL] [Abstract][Full Text] [Related]
23. [Evaluation of direct microscopic examination, acridine orange staining and culture methods for studies of Trichomonas vaginalis in vaginal discharge specimens].
Cevahir N; Kaleli I; Kaleli B
Mikrobiyol Bul; 2002; 36(3-4):329-35. PubMed ID: 12838668
[TBL] [Abstract][Full Text] [Related]
24. Clinical evaluation of affirm VPIII in the detection and identification of Trichomonas vaginalis, Gardnerella vaginalis, and Candida species in vaginitis/vaginosis.
Brown HL; Fuller DD; Jasper LT; Davis TE; Wright JD
Infect Dis Obstet Gynecol; 2004; 12(1):17-21. PubMed ID: 15460191
[TBL] [Abstract][Full Text] [Related]
25. The association between copper containing IUCD and bacterial vaginosis.
Demirezen S; Küçük A; Beksaç MS
Cent Eur J Public Health; 2006 Sep; 14(3):138-40. PubMed ID: 17152227
[TBL] [Abstract][Full Text] [Related]
26. The role of Gardnerella vaginalis in nonspecific vaginitis in intra uterine contraceptive device users.
Gupta BK; Kumar R; Sofat R; Khurana S; Deepinder
Indian J Pathol Microbiol; 1998 Jan; 41(1):67-70. PubMed ID: 9581079
[TBL] [Abstract][Full Text] [Related]
27. Comparison of conventional testing to polymerase chain reaction in detection of Trichomonas vaginalis in indigenous women living in remote areas.
Smith KS; Tabrizi SN; Fethers KA; Knox JB; Pearce C; Garland SM
Int J STD AIDS; 2005 Dec; 16(12):811-5. PubMed ID: 16336764
[TBL] [Abstract][Full Text] [Related]
28. Association of mast cells with vaginal trichomoniasis in endocervical smears.
Kobayashi TK; Fujimoto T; Okamoto H; Yuasa M; Sawaragi I
Acta Cytol; 1983; 27(2):133-7. PubMed ID: 6601348
[TBL] [Abstract][Full Text] [Related]
29. Real-time ultrasound in locating intrauterine contraceptive devices.
Nelson LH; Miller JB
Obstet Gynecol; 1979 Dec; 54(6):711-4. PubMed ID: 514557
[TBL] [Abstract][Full Text] [Related]
30. Frequency of infectious agents for vaginitis in non- and hysterectomized women.
Murta EF; Silva AO; Silva EA; Adad SJ
Arch Gynecol Obstet; 2005 Dec; 273(3):152-6. PubMed ID: 16021494
[TBL] [Abstract][Full Text] [Related]
31. The diagnosis of trichomonas vaginalis in liquid-based Pap tests: morphological characteristics.
Aslan DL; McKeon DM; Stelow EB; Gulbahce HE; Kjeldahl K; Pambuccian SE
Diagn Cytopathol; 2005 May; 32(5):253-9. PubMed ID: 15830365
[TBL] [Abstract][Full Text] [Related]
32. A novel method to increase the viability of Trichomonas vaginalis in urine.
Shafir SC; Sorvillo FJ; Upcroft JA; Upcroft P
Sex Transm Dis; 2007 Jul; 34(7):485-7. PubMed ID: 17589330
[TBL] [Abstract][Full Text] [Related]
33. [A comparative study of the incidence of Gardnerella vaginalis in users of IUD and oral contraceptives].
Aleixo Neto A; Peixoto ML; Cabral AC
J Bras Ginecol; 1987 Jul; 97(7):315-6. PubMed ID: 12282423
[TBL] [Abstract][Full Text] [Related]
34. Pelvic inflammatory disease among women using copper IUDs, Progestasert, oral contraceptive pills or vaginal contraceptive pills: a 4-year prospective investigation.
Larsson B; Rodau S; Patek E
Contracept Deliv Syst; 1981 Jul; 2(3):237-42. PubMed ID: 12278910
[TBL] [Abstract][Full Text] [Related]
35. [An analysis of complications and bacteriological and histological studies following extraction of an intrauterine contraceptive device (Beospir) which was inserted several years ago].
Kracunović M; Oprić M
Jugosl Ginekol Opstet; 1980; 19(3-4):191-4. PubMed ID: 7412377
[TBL] [Abstract][Full Text] [Related]
36. Trichomonas vaginalis among HIV-Infected women: are immune status or protease inhibitor use associated with subsequent T. vaginalis positivity?
Magnus M; Clark R; Myers L; Farley T; Kissinger PJ
Sex Transm Dis; 2003 Nov; 30(11):839-43. PubMed ID: 14603092
[TBL] [Abstract][Full Text] [Related]
37. Actinomycete-like organisms in cervicovaginal smears.
Fry R; Linder AM; Bull MM
S Afr Med J; 1980 Jun; 57(25):1041-3. PubMed ID: 7404087
[TBL] [Abstract][Full Text] [Related]
38. [Experimental study of a cupro-contraceptive intrauterine device (copper 7: Gravigarde)].
Levrier M
Gynecologie; 1974; 25(1):35-40. PubMed ID: 4420221
[No Abstract] [Full Text] [Related]
39. Performance of a new, rapid assay for detection of Trichomonas vaginalis.
Kurth A; Whittington WL; Golden MR; Thomas KK; Holmes KK; Schwebke JR
J Clin Microbiol; 2004 Jul; 42(7):2940-3. PubMed ID: 15243042
[TBL] [Abstract][Full Text] [Related]
40. Bare Trichomonas vaginalis nuclei in cervicovaginal smears.
Hollander DH
Acta Cytol; 1982; 26(1):96-7. PubMed ID: 6977980
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
